Medacta Group SA (SWX:MOVE)
Switzerland · Delayed Price · Currency is CHF 113.40
-0.20 (-0.18%)
Oct 2, 2026, 5:30 PM CET
Medacta Group Market Cap
Medacta Group has a market cap or net worth of 2.26 billion as of October 2, 2026. Its market cap has decreased by -20.58% in one year.
Market Cap
2.26B
Enterprise Value
2.52B
Revenue
653.43M
Ranking
n/a
PE Ratio
31.74
Stock Price
113.40
ChartMarket Cap Chart
Since April 4, 2019, Medacta Group's market cap has increased from 1.92B to 2.26B, an increase of 17.68%. That is a compound annual growth rate of 2.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 2.26B | -27.49% |
| Dec 30, 2025 | 3.12B | 46.66% |
| Dec 30, 2024 | 2.13B | -15.15% |
| Dec 29, 2023 | 2.51B | 21.81% |
| Dec 30, 2022 | 2.06B | -27.53% |
| Dec 30, 2021 | 2.84B | 62.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 279.40B |
| Novartis AG | 228.01B |
| Lonza Group AG | 39.15B |
| Galderma Group AG | 37.50B |
| Galenica AG | 4.07B |
| Siegfried Holding AG | 3.15B |
| Tecan Group AG | 2.89B |
| SKAN Group AG | 1.59B |